IRF3 and neuroblastoma: IFN‐β treatment has been shown to downregulate the PI3K/Akt pathway in neuroblastoma cells, and it is conceivable that IRF3‐induced p‐AKT inhibition is mediated through the IFN‐β/PI3K pathway.52